Claravine Honors Indegene as the Inaugural MVP Awardee
The Data Standards Company awards Indegene for its efforts in compliant marketing practices for life science brands.
Claravine, The Data Standards Company, has awarded the inaugural Claravine MVP Partner Award to Indegene, a digital-first life sciences commercialization company, which counts the world’s top 20 biopharma companies among its clientele. This recognition acknowledges Indegene’s commitment to excellence in data standards and technology integration and its successful collaboration with Claravine. Indegene co-innovates and closely collaborates with global life sciences, emerging biotech, and medical device companies.
Powering Data Standards That Drive Impact
The Indegene-Claravine partnership delivers a comprehensive data standards solution, improving accuracy, compliance, and efficiency. This is crucial for life sciences brands seeking to ensure regulatory compliance, maintain data integrity, and make informed decisions based on reliable data. The Indegene team has earned 50 certifications through Claravine Academy’s MVP program and data standards training, reflecting a strong commitment to operational excellence and scalable cloud practices within the company.
The partnership exemplifies the power of data standards, helping life sciences brands deliver better patient experiences with data they can trust. By combining Indegene’s deep domain expertise and Claravine’s data standards, the two companies are creating a resilient digital ecosystem that is primed for the future of life sciences marketing.
Indegene continues to build and deliver exceptional campaign data governance, digital measurement frameworks, and analytics experiences to its clients around the world by leveraging Claravine’s Data Standards Cloud Platform. Indegene has also created an analytics ecosystem to capture and analyze data effectively, helping life sciences organizations unlock value by managing complex implementations, achieving efficiencies, and accelerating business goals and outcomes.
